(2021). Lopinavir/ritonavir: Hepatobiliary disorder and hypertriglyceridaemia following off label use: case report. Reactions Weekly.
Čikaški stil citiranja"Lopinavir/ritonavir: Hepatobiliary Disorder and Hypertriglyceridaemia Following Off Label Use: Case Report." Reactions Weekly 2021.
MLA način citiranja"Lopinavir/ritonavir: Hepatobiliary Disorder and Hypertriglyceridaemia Following Off Label Use: Case Report." Reactions Weekly 2021.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.